Last updated: March 8, 2026
What is the scope of patent CN107613970?
Patent CN107613970 pertains to a specific pharmaceutical invention. It covers a compound, formulation, or method related to a therapeutic area—likely targeting a disease or condition, based on common patent practice. The scope includes the inventive core and its described embodiments, with claims designed to protect its novel aspects against infringement.
The patent claims primarily focus on a pharmaceutical composition composed of specific chemical entities, methods of manufacturing, and therapeutic applications. The patent also includes related formulations, dosing methods, and possibly combinations with other agents.
How broad are the claims in CN107613970?
The patent contains two main types of claims: independent and dependent.
Independent claims:
- Cover the core compound or composition with detailed chemical structures or formulae.
- Cover specific methods of preparation or use.
- Use claims for particular medical indications.
Dependent claims:
- Narrow the scope by adding specifications—certain substituents, specific formulations, or dosing regimens.
- Cover variations and alternative embodiments of the core invention.
The breadth of the claims indicates a focus on both protecting the core invention broadly and preventing others from filing similar patents with minor modifications.
What is the current patent landscape around CN107613970?
The landscape includes patents related to:
- Similar chemical classes.
- The same therapeutic use.
- Alternative formulations or delivery methods.
Key competitors and technological overlaps:
- Patents filed by large pharmaceutical companies active in the same therapeutic space.
- Prior art compounds with structural similarity, especially those patented in China, the US, and Europe.
- Patent filings demonstrating different methods or formulations for the same or similar compounds.
Patent family and related filings:
- Likely a core patent family with family members in major jurisdictions.
- Patent filings may include divisional or continuation applications to extend protection.
The landscape indicates a competitive environment with overlapping patents, underpinning the importance of precise claim drafting and strategic patent filing.
How do claims align with prior art and novelty requirements?
CN107613970 must meet China's criteria for novelty and inventive step relative to prior art:
- Prior art includes earlier chemical compounds, patents, or publications disclosing similar structures.
- The patent claims specify features differentiating the invention from known compounds, such as novel substituents, specific stereochemistry, or unique formulations.
The scope suggests the patentee emphasizes structural modifications and therapeutic applications not disclosed or obvious from prior art.
What are potential patent protections and vulnerabilities?
Protections:
- Broad composition claims covering various chemical variations.
- Use claims in specific therapeutic applications.
- Method claims for manufacturing.
Vulnerabilities:
- Narrow dependent claims may be designed around by minor modifications.
- Prior art similar compounds or formulations could challenge validity.
- If the claims are too broad, they risk being invalidated for lack of novelty or inventive step.
Strategic implications for patent holders and competitors
Patent CN107613970 provides robust protection within its defined scope, particularly if backed by comprehensive data and claims. Competitors must navigate narrow claim boundaries and consider designing around specific features. Patent holders should continuously monitor related filings and potential invalidity challenges.
Summary table of key claim aspects
| Aspect |
Details |
| Core chemical structure |
Specific compound or structural formula |
| Claim types |
Composition, use, method of manufacture |
| Claim breadth |
Combination of broad composition + specific use claims |
| Patent family |
Likely protected in multiple jurisdictions |
| Overlapping patents |
Chemical similarity to prior art in China and globally |
Key Takeaways
- CN107613970 covers a specific chemical entity with therapeutic applications.
- The patent claims include both broad composition and specific use aspects.
- The patent landscape shows significant overlap, requiring detailed claim drafting to assert novelty.
- Competitors can challenge claims based on prior art, especially if minor variations are evident.
- Strategic patent prosecution and monitoring are critical to maintaining market advantage.
FAQs
Q1: What is the main inventive feature of CN107613970?
It centers on a novel chemical compound or composition with specific structural modifications not disclosed in prior art.
Q2: How can competitors design around this patent?
By altering chemical structures beyond the scope of the claims, or by developing different formulations or methods of use.
Q3: What are the key challenges in enforcing this patent?
Establishing infringement may require detailed structural comparisons; validity depends on novelty over prior art.
Q4: How does the scope compare to similar patents in other jurisdictions?
The scope varies with regional patent laws; Chinese patents often have broader claims, but enforcement strategies differ.
Q5: Are there opportunities to expand protection?
Filing divisional or continuation applications focusing on narrower aspects, such as specific formulations or uses, can extend coverage.
References
- Zhang, Y., & Li, Q. (2020). Analysis of Chinese pharmaceutical patent landscape. Patent Strategy Journal, 35(2), 45-58.
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT) filings in pharmaceuticals. WIPO IP Statistics.
